Pritish Nandy Communications will hold a meeting of the Board of Directors of the Company on 27 January 2022
Laurus Labs will hold a meeting of the Board of Directors of the Company on 27 January 2022
Response Informatics will hold a meeting of the Board of Directors of the Company on 27 January 2022
Lagnam Spintex announced that the Board of Directors of the Company at its meeting held on 15 January 2022 inter alia have recommended the interim dividend of Rs 05 per equity Share ie 5Percentage subject to the approval of the shareholders
Dr Habeebullah Life Sciences will hold a meeting of the Board of Directors of the Company on 27 January 2022
Saregama India announced that the Board of Directors of the Company at its meeting held on 19 January 2022 has recommended a Interim dividend of Rs30 per share ie300Percentage subject to the approval of the shareholders
Jupiter Infomedia will hold a meeting of the Board of Directors of the Company on 27 January 2022
Cil Securities will hold a meeting of the Board of Directors of the Company on 28 January 2022
Glenmark Pharmaceuticals today announced that its Swiss subsidiary Glenmark Specialty SA has entered into an exclusive licensing agreement with Lotus International a wholly owned subsidiary of Lotus Pharmaceutical Co Ltd Lotus for commercializing its innovative nasal spray Ryaltris in Singapore Hong Kong and Vietnam Under the terms of the agreement Glenmark will be responsible for the manufacture and supply of Ryaltris whereas Lotus will be […]
Suven Pharmaceuticals announced the resignation of Dr Chandrasekhar Srivari DIN 00481481 from the post of non-executive independent director of the company with effect from 19 January 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
